Blood News and Research

RSS

Fetal and neonatal therapy combination may lessen the aftereffects of congenital CMV infection

A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.

28 Jan 2021

NUS researchers discover a mechanism controlling the replenishment of blood cells

Blood is vital to life, and a healthy body replenishes worn-out blood cells with new ones throughout one's lifetime. If something goes wrong with this process, serious illness will result.

28 Jan 2021

Researchers develop a simple and efficient way to generate hemogenic endothelial cells

Pioneering research into how our bodies manufacture the cells that make blood has moved us closer to regrowing tissues and organs. The findings also may let doctors grow the cells for transplantation into people to battle cancer, blood disorders and autoimmune diseases.

28 Jan 2021

Early plasma markers help track the progression of Alzheimer's disease

A Quebec research team has discovered two early plasma markers to detect Alzheimer's disease five years before its onset.

28 Jan 2021

Substances in tick saliva activate immune response-suppressing proteins in cattle

A tick saliva study reveals immune responses that could lead to better protection for cattle.

28 Jan 2021

Moderna vaccine shows robust suppression of SARS-CoV-2 infection in animal model

Researchers have demonstrated that the prime or prime-boost vaccination of Moderna vaccine in hamsters induced robust neutralizing antibodies, ameliorated weight loss, and suppressed SARS-CoV-2 replication in the airways.

28 Jan 2021

COVID-19 patients in high-altitude ICUs had improved survival in case study

A team of researchers in Ecuador and the U.K. found that high altitudes may be linked to improved COVID-19 survival – particularly among patients with no comorbidities.

28 Jan 2021

David Julius and Ardem Patapoutian receive Frontiers of Knowledge Award in Biology and Biomedicine

The BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine has gone in this thirteenth edition to David Julius, from the University of California, San Francisco, and Ardem Patapoutian, from the Scripps Institute, La Jolla (United States), "for identifying the receptors that enable us to sense temperature, pain and pressure."

28 Jan 2021

Ebola survivors experienced a resurgence in antibody levels after recovery

A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.

27 Jan 2021

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.

27 Jan 2021

Researchers figure out how the immune system keeps tabs on the brain

Alzheimer's disease, multiple sclerosis, autism, schizophrenia and many other neurological and psychiatric conditions have been linked to inflammation in the brain.

27 Jan 2021

Insight into cancer cells' own first aid could provide the basis for new immunotherapy

Insight into cancer cells' own first aid could help the development of a new type of treatment. Johanna Olweus and her team at the UiO (University of Oslo) and the OUS (Oslo University Hospital) are important contributors to this study, which has been published in Nature.

27 Jan 2021

New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis

A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine, has secured a five-year grant from the National Institutes of Health National Heart, Lung, and Blood Institute.

27 Jan 2021

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo Center for Brain Health to study the therapeutic potential of the anti-cancer drug lenalidomide in early-stage Alzheimer's disease, known as mild cognitive impairment.

27 Jan 2021

Study shows how aneuploidy could become a weak point for cancer cells

What makes cancer cells different from ordinary cells in our bodies? Can these differences be used to strike at them and paralyze their activity? This basic question has bothered cancer researchers since the mid-19th century.

27 Jan 2021

Study uncovers a novel promising target for diabetes treatment

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery.

27 Jan 2021

Blood News and Research

Fetal and neonatal therapy combination may lessen the aftereffects of congenital CMV infection

NUS researchers discover a mechanism controlling the replenishment of blood cells

Researchers develop a simple and efficient way to generate hemogenic endothelial cells

Early plasma markers help track the progression of Alzheimer's disease

Substances in tick saliva activate immune response-suppressing proteins in cattle

Moderna vaccine shows robust suppression of SARS-CoV-2 infection in animal model

COVID-19 patients in high-altitude ICUs had improved survival in case study

David Julius and Ardem Patapoutian receive Frontiers of Knowledge Award in Biology and Biomedicine

Ebola survivors experienced a resurgence in antibody levels after recovery

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Researchers figure out how the immune system keeps tabs on the brain

Insight into cancer cells' own first aid could provide the basis for new immunotherapy

New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

Study shows how aneuploidy could become a weak point for cancer cells

Study uncovers a novel promising target for diabetes treatment

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

Anakinra shows therapeutic potential in critically ill COVID-19 patients

If I have cancer, dementia or MS, should i get the covid vaccine?

New method replicates bone tissue complexity, bone remodeling processes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News